Gilead Sciences (GILD) Short term Debt (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Short term Debt data on file, last reported at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Short term Debt fell 53.21% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (down 53.21% YoY), and the FY2025 full-year result was $2.8 billion, up 54.66% from the prior year.
• Short term Debt for Q1 2026 stood at $1.3 billion, down from $2.8 billion in the prior quarter.
• Across five years, Short term Debt topped out at $4.0 billion in Q2 2023 and bottomed at $1.0 billion in Q2 2022.
• The 5-year median for Short term Debt is $2.3 billion (2022), against an average of $2.2 billion.
• The widest annual swing landed in 2023, when Short term Debt surged 295.4%; it then plunged 55.16% in 2024.
• A 5-year view of Short term Debt shows it stood at $2.3 billion in 2022, then decreased by 20.9% to $1.8 billion in 2023, then advanced by 0.95% to $1.8 billion in 2024, then surged by 54.66% to $2.8 billion in 2025, then plunged by 53.22% to $1.3 billion in 2026.
• The last three Short term Debt figures came in at $1.3 billion (Q1 2026), $2.8 billion (Q4 2025), and $2.8 billion (Q3 2025), per Business Quant data.

Peer Comparison